Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7342826

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,929,986,000 JPY
-1,204,506,000 JPY
Non-operating income
Non-operating income
32,208,000 JPY
63,267,000 JPY
Non-operating expenses
Non-operating expenses
16,038,000 JPY
21,769,000 JPY
Ordinary profit (loss)
-1,913,816,000 JPY
-1,163,008,000 JPY
Extraordinary income
Extraordinary income
136,000 JPY
21,406,000 JPY
Extraordinary losses
Extraordinary losses
21,898,000 JPY
4,403,000 JPY
Profit (loss) before income taxes
-1,935,578,000 JPY
-1,146,005,000 JPY
Income taxes - current
2,926,000 JPY
2,932,000 JPY
Profit (loss)
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,148,938,000 JPY
-1,148,938,000 JPY
-1,148,938,000 JPY
-1,148,938,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.